How common are retrocerebellar (posterior‑fossa) arachnoid cysts?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Prevalence of Retrocerebellar (Posterior Fossa) Arachnoid Cysts

Retrocerebellar arachnoid cysts are relatively common, representing approximately 33% of all intracranial arachnoid cysts in adults, making them the second most frequent location after middle fossa cysts. 1

Overall Prevalence Data

  • Arachnoid cysts occur in approximately 1.4% of adults undergoing brain MRI, based on a large retrospective study of 48,417 consecutive patients 1
  • The overall prevalence ranges from 1-2% in the general population 2
  • Men have a significantly higher prevalence than women (p < 0.0001) 1

Location-Specific Distribution

The distribution of arachnoid cysts by location shows:

  • Middle fossa: 34% (most common location) 1
  • Retrocerebellar/posterior fossa: 33% (second most common) 1
  • Convexity: 14% 1
  • Other locations (sellar, suprasellar, etc.) comprise the remainder 1

Clinical Context

Posterior fossa arachnoid cysts are considered "uncommon" in the posterior cranial fossa compared to other intracranial locations, though they still represent a substantial proportion of all arachnoid cysts 3, 4. These cysts constitute approximately 1% of all intracranial masses overall 3.

Important Clinical Characteristics

  • Multiple arachnoid cysts can occur in the same patient (occurred in 30 of 661 patients, or 4.5%) 1
  • Posterior fossa cysts generally remain asymptomatic or cause vague, non-specific symptoms 4
  • When symptomatic, they may present with headaches, seizures, focal neurologic signs, or rarely isolated sensorineural hearing loss 3, 4

Natural History

The vast majority of posterior fossa arachnoid cysts remain stable over time, with only 2.3% increasing in size during follow-up (mean 3.8 years) 1. This benign natural history supports conservative management for asymptomatic cases 5, 1.

References

Research

Arachnoid cyst of the cranial posterior fossa causing sensorineural hearing loss and tinnitus: a case report.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2002

Guideline

Arachnoid Cysts: Growth Potential and Clinical Implications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the recommended treatment approach for a patient presenting with an arachnoid cyst?
Do individuals with an arachnoid cyst require a neurologist consultation?
What is the management approach for a cisterna magna arachnoid cyst?
What is the management and treatment of arachnoid cysts?
What is the recommended management for a 3-month-old infant with a large posterior fossa arachnoid cyst?
How should rigors associated with influenza be managed, including antiviral therapy, antipyretics, supportive care, and criteria for urgent medical attention, particularly in high‑risk patients?
How should an elevated rheumatoid factor be evaluated and managed, including work‑up for rheumatoid arthritis versus other possible causes?
Should supplemental oxygen be administered to an adult with diabetic ketoacidosis only if hypoxemia (SpO₂ < 94 % or PaO₂ < 60 mm Hg) or respiratory compromise is present?
What is the incidence and recommended management of retrocerebellar (posterior fossa) arachnoid cysts in newborns?
What is the recommended cross‑taper schedule to switch an adult patient without liver disease, renal impairment, or pregnancy from lamotrigine (Lamictal) to valproic acid (Depakote) due to inadequate response or intolerable side effects?
For a healthy 33‑year‑old Indian male with severe gut dysbiosis lacking Bifidobacterium longum, Bifidobacterium bifidum, Lactobacillus acidophilus, Lactobacillus rhamnosus and Lactobacillus plantarum, which of the available probiotics (Opti Biotic, VSL#3, Visbiome, Seed DS‑01) best matches his deficiencies, is a full ≥100 billion CFU dose safe or should he start with half the dose, are any strains problematic in a Prevotella‑dominant microbiota, and should the capsules be taken with food or on an empty stomach for optimal colonization?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.